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INTRODUCTION 
 
Skeletal Myotube 
Skeletal muscle is exquisitely tailored for skeletal stabilization, force generation and 
coordinated movement. Unlike most tissues, it does not consist of individual cells; rather it is 
formed from huge, multinucleate muscle fibers, which develop by fusion forming a syncytium 
of many individual cells, called myoblasts. For coordinated action the entire fiber contracts 
together as a single unit. Synchronization of contraction along the length of the fiber is 
accomplished by the muscle fiber action potential which zips rapidly along the fiber after being 
triggered by neurotransmitter release at the motor end plate upon arrival of a motor axon action 
potential. The depolarization signal is transmitted uniformly throughout the cell by means of 
transverse (or T-) tubules (Fig.1), which are invaginations of the surface plasma membrane 
closely juxtaposed to the membrane of the sarcoplasmic reticulum (SR). The SR is the Ca2+- 
storage compartment of the muscle whose membranes are rich in active transport systems, like 
e.g., the Ca2+-ATPase pump (SERCA), that pumps intracellular Ca2+ back into the SR. Around 
the myofibrils the SR forms a network of longitudinal tubules, with enlarged sacs at its end, 
called terminal cisternae. The juxtaposition of two terminal cisternae of SR and one T-tubule 
creates a functional unit, called the triad (Fig.1).  
 
 
 
 
 
 
 
    
Fig. 1: Skeletal myotube. Action potentials 
move along the membrane and are transmitted 
to the entire cell via T-tubules that are closely 
juxtaposed to the membranes of terminal SR 
cisternae and thus forming the triads. There, 
membrane depolarization is converted into 
muscle-contraction.  
Saladin et al. (2004), Anatomy & Physiology: 
The unit of form and function. 
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Exactly at the triad the interaction between two distinct Ca2+ channels, the voltage-gated L-type 
Ca2+ channel or dihydropyridine receptor (DHPR), located in the T-tubule’s plasma membrane 
and the skeletal muscle Ca2+ release channel or ryanodine receptor (RyR1), situated in the SR 
membrane, mediates the conversion of membrane depolarization into muscle-contraction 
(excitation-contraction coupling). 
 
Dihydropyridine Receptor (DHPR)  
The dihydropyridine receptor DHPR is a voltage-gated L-type Ca2+ channel, located in the 
membrane of the T-tubule, essential in excitation-contraction (EC) coupling 1. This channel is a 
multi-subunit complex, composed of a pore-forming α1 subunit and the auxiliary α2δ, β and γ 
subunits (Fig.2).  
 
 
Fig. 2. DHPR. It is a multi-subunits complex. The main subunit α1S acts as pore, gate and voltage-sensor of the 
channel. It interacts directly with the cytoplasmic β subunit and the two transmembrane/extracellular subunits 
α2δ  and γ. These auxiliary subunits modulate the expression and the functions of the Ca2+ channel.  
 
 
The central subunit of the skeletal muscle Ca2+ channels is α1S, which acts as voltage-sensor 
and Ca2+ selectivity filter. The α1 subunit is a protein of 193kDa, resembling in its primary and  
secondary structure the α subunit of the voltage-gated Na+ channel (Fig.3). 
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It consists of four repeated (“homologous”) domains (I to IV), each with six transmembrane α-
helical segments (S1-S6) and a membrane-associated loop between S5 and S6 (pore loop). 
Like in other voltage sensitive channels, α1S is gated open and closed by the position of few 
positive charged residues that move in response to changes in the membrane potential. These 
charges are localized in the S4 segments of each repeated domain and serve as voltage sensor 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. The pore-forming subunit of the DHPR. The α1 subunit consists of four repeated domains (I-IV), each 
with six transmembrane segments. The S4 segments are positively charged (+) and function as voltage-sensor of 
the channel. The four glutamates (red) in the S5-S6 p-loops contribute to the channel selectivity for Ca2+ ions. The 
I-II linker contains the AID sequence motif whereas the II-III linker is responsible for coupling of α1S with RyR. 
 
 
The channel’s selectivity for Ca2+ is dependent on the high-affinity binding of Ca2+ within the 
pore. This binding site involves four conserved glutamate residues, in equivalent positions in 
all the S5-S6 pore loops 3. The α1S subunit contains binding sites for pharmacological active 
drugs, the so-called Ca2+ channel blockers, phenylalkylamines (PAA), benzothiazepines 
(BTZ), and 1,4-dihydropyridines (DHP) as well as the molecular domains for interactions with  
the accessory subunits and with the RyR1. The cytoplasmic linker between the domains I and 
II contains a conserved motif of nine amino acids, the AID (Alpha Interaction Domain) that  
mediates the interaction between α1 and β subunits 4, 5. Another important region of α1S is a 
short segment of 45 amino acid (residues 720-765) in the II-III linker, that is responsible for  
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bidirectional-signaling interactions with RyR16. The β subunit is a cytoplasmic protein which 
interacts with the DHPR complex via BID (Beta Interaction Domain) 4. The β subunit is 
essential for the development of functional skeletal muscle: its absence eliminates EC coupling 
and modifies the Ca2+ currents in skeletal muscle cells7. Schredelseker et al. 8showed that the 
skeletal muscle β1 subunit is essential for the skeletal muscle-specific arrangement of DHPR 
with RyR, a prerequisite for EC coupling. In contrast, the other two auxiliary subunits, α2δ and 
γ  are functional modulators of the Ca2+ channel. The α2δ complex is a disulfide-linked 
heterodimer, the product of a single gene that is post-translationally cleaved. It is anchored in 
the T-tubule membrane by a transmembrane segment in the δ subunit and is an important 
determinant of the kinetic properties of the L-type Ca2+ currents 9. The γ subunit, expressed 
exclusively in skeletal muscle, is targeted to the surface membrane in the absence of the α1 but 
requires the α1 subunit for its association to the DHPR complex10 and for the negative 
modulation of the Ca2+ currents 11. 
 
Ryanodine Receptor (RyR) 
The ryanodine receptor, is the Ca2+ release channel of the SR membrane. There are three 
different isoforms of RyR (RyR1, RyR2, RyR3), encoded by three different genes. The 
predominant RyR isoform in skeletal muscle is the RyR1 protein, commonly referred to as the 
skeletal RyR isoform. RyRs consist of polypeptides of approximately ~560 kDa arranged in a 
homotetrameric structure with at least two functional domains: a carboxyl-terminal 
transmembrane domain containing the conduction pore of the Ca2+ release channel and a large 
amino-terminal cytoplasmic domain referred to as the "foot structure" 12. The activity of the 
skeletal muscle Ca2+ release channel is modulated by a wide spectrum of endogenous and  
exogenous ligands like Mg2+, ATP, calmodulin, caffeine and it is regulated in a biphasic 
manner by ryanodine and Ca2+. Low concentrations (nanomolar) of ryanodine activate the 
channel, whereas high concentrations (>100 µM) inhibit the channel activity. In the same way,  
the RyR channel is activated by low Ca2+ concentrations (1-10 µM) and inhibited by high Ca2+ 
concentrations (1-10 mM). Ca2+ regulation plays a role in all RyR-mediated signaling cascades.  
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While in skeletal muscle the regulating Ca2+ signal may amplify RyR1 channel activity only to 
a limited extent, the Ca2+ signal in cardiac muscle even initiates RyR2 channel activity (trigger 
Ca2+). 
 
Excitation-Contraction Coupling (EC) 
The functional interaction between the DHPR and RyR1 is commonly referred to as EC 
coupling. Depolarization of the T-tubule membrane (excitation) induces conformational 
changes in the DHPR that leads to activation of RyR resulting in a massive Ca2+ release from 
the SR. The transient increase of intracellular Ca2+ activates the contractile apparatus of the 
muscle fibers. The interaction between these two channels in cardiac muscle employs a 
different mechanism compared with that in skeletal muscle. In cardiac muscle, the L-type 
channel opens rapidly and generates a large inward influx of Ca2+ which induces Ca2+ release 
through the cardiac-type ryanodine receptor (RyR2) - a process called Ca2+-induced Ca2+ 
release (CICR)13. In contrast, in skeletal muscle cells Ca2+ release is independent of Ca2+ influx 
through DHPR.  In fact, the application of Ca2+ current blockers does not affect EC coupling 14, 
15. Skeletal muscle DHPR functions predominantly as voltage sensor and activates RyR1 by 
direct protein-protein interaction16.  
 
 
 
 
 Fig. 4. Skeletal muscle-type EC coupling.     In 
skeletal muscle, DHPR and RyR1 are physically 
and functionally linked to each other within the 
junctional domains. The T-tubule contains groups 
of four DHPRs (tetrads). Every other RyR1 
channel is associated with such a DHPR tetrad. 
Membrane voltage changes ( VM) activate the 
DHPR and trigger the RyR1 channel to open and 
release the Ca2+ stored inside the sarcoplasmic 
reticulum (SR) (from Fill and  Copello, 2002) 
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The physiological difference in the EC coupling mechanisms in the two muscle types is 
reflected in the structural arrangements of DHPRs and RyRs in the junctional domains. 
In skeletal muscle, four DHPRs are grouped to form a so called tetrad, located in exact 
correspondence to RyRs 17, 18. Furthermore RyR1 channels are disposed in orthogonal arrays 
where every other RyR is associated with a DHPR tetrad. This arrangement is indicative of the 
physical coupling between DHPRs and RyRs, a feature indispensable for the Ca2+- independent 
skeletal-type EC coupling 19. 
 
Malignant Hyperthermia 
Abnormalities in Ca2+ regulatory proteins can lead to different muscle diseases like Malignant 
Hyperthermia (MH) or Central Core Disease (CCD) and multi-minicore disease (MmM). MH 
is a potentially lethal pharmacogenetic disorder of skeletal muscle, inherited in an autosomal 
dominant mode. The incidence of MH episodes during anesthesia is between 1:5,000 and 
1:50,000–100,000 anesthesias whereas the estimated prevalence of the genetic abnormalities 
may be as high as 1:3000 individuals (range 1:3,000 to 1:8,500)20. MH clinical episodes are 
triggered in susceptible individuals by exposure to volatile anesthetics (halothane) or 
depolarizing muscle relaxants. An MH crisis is characterized by increased muscle metabolism 
and heat production resulting in a progressive hyperthermia and muscle rigidity associated with 
tachycardia, metabolic acidosis, hyperkalemia and hypoxia. Apart from induced crisis 
episodes, MH patients do not present clinically relevant symptoms. Because of its subclinical 
nature, MH susceptibility has to be usually diagnosed by an invasive in vitro contracture test 
(IVCT). According to the European standardized protocol21, the contracture responses of 
muscle tissue upon the exposure to halothane and caffeine discriminate individuals as MH 
susceptible (MHS), MH normal (MHN) and MH equivocal (MHE). The last category 
encompasses patients who react abnormally to one but not both of the triggering agents used. 
Unfortunately, so far the diagnosis of MH susceptibility cannot be made using a simple genetic 
test because the high level of genetic heterogeneity does not avoid the risk of false MH-
negative diagnoses. However, there may be situations where genetic data provide additional  
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diagnostic information or contribute information independent of IVCT, according to the 
recently diagnostic guidelines from the European MH Group 22. 
All the symptoms of the MH crisis demonstrate the relevant consequences of altered EC 
coupling that results in an abnormal and uncontrolled Ca2+ release from SR stores within 
skeletal muscle following the administration of anesthetics and muscle relaxants. 
 
 
Genetic heterogeneity of MH 
Malignant hyperthermia displays a high level of locus heterogeneity. The first molecular 
genetic studies had shown that the human MHS trait maps to the ryanodine receptor locus 
(RYR1 gene) on chromosome 19q13.1 23, 24. The RYR1gene encodes the skeletal muscle Ca2+ 
release channel of the SR. Linkage studies established RYR1 as the main MH causing gene 
that accounts for susceptibility in more than 50% of MH families. So far, more than 150 
mutations, clustered in structurally and functionally definable areas in RyR1, have been 
identified in MHS families 25 but only 28 of them have been functionally validated 
(www.emhg.org) and can be used for molecular diagnosis. With the exclusion of linkage 
between MHS and RYR1 on several occasions 26, it has become apparent that the genetic basis 
of MH is very complex. As MH is thought to be induced primarily by abnormalities in skeletal 
muscle Ca2+ homeostasis, the five protein-subunits of DHPR encoded by four separate genes 
have been considered as plausible candidate genes for MHS. So far, from this entire complex,  
only the CACNA1S gene encoding the DHPR-α1S subunit on chromosome 1q32 27, 28  (MHS5, 
MIM 601887) and the gene encoding the DHPR-α2δ subunit on chromosome 7q21-22 29 
(MHS3, MIM 154276) showed association to MH susceptibility. A genome wide search has 
identified 3 additional MHS loci. One of these locates on chromosome 17q11-24 30 (MHS2, 
MIM 154275), the site of the SCN4A gene encoding the α subunit of the sodium channel. The 
other two loci are on chromosome 3q13.1 31 (MHS4, MIM 600467) and 5p 32 (MHS6, MIM 
601888), where no candidate genes have been identified so far. 
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Aim of this thesis 
This Ph.D. thesis presents the functional characterization of a new MH point mutation, 
T1354S, identified in the CACNA1S gene 28. As described in my degree thesis, we found co-
segregation of markers close to the CACNA1S gene in all MHS individuals of a south Italian 
family. LOD-score values between these markers and the disease were equal or close to 1.76, 
the maximal expected value for this pedigree. DNA sequence analysis of the CACNA1S gene 
of MHS members of the family revealed the presence of an A4062T transversion in exon 33 at 
the heterozygous status resulting in the substitution of threonin 1354 for serine (T1354S). The 
substituted amino acid residue is located in the IVS5-S6 extracellular P-loop of α1S. Mutation 
T1354S was detected neither in related MH normal individuals nor in 134 unrelated control 
subjects. Here I present investigations of the effects of the T1354S mutation on the assembly 
and function of the EC-coupling apparatus after transiently expressing the mutant α1S T1354S 
in dysgenic (α1S null) murine myotubes.  
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MATERIALS AND METHODS 
 
? Dysgenic myotubes 
? Immunocytochemistry 
? Patch-clamp 
? Caffeine response curve 
? Field stimulation 
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Dysgenic Myotubes 
All the experiments were performed in dysgenic (α1S - null) myotubes, explicitly GLT and 
MDG.  
? The skeletal muscle cell line GLT derived from dysgenic-mouse skeletal muscle cells 33, 
transfected with a plasmid encoding a Large T antigen 34. GLTs muscle cells are flatter than 
the primary cultures and they need to be adherent to the substrate to grow and differentiate. 
These cells lack the α1S subunit of DHPR while the α2δ is present but not correctly 
targeted. Nevertheless, RyRs are normally expressed and clustered in correspondence of 
the T-tubule/SR junctions, thus we can observe in GLTs only Ca2+ release induced by 
caffeine but not spontaneous or depolarization-induced Ca2+ release from SR. 
Mononucleated GLT cells are continuously cultured in growth medium (GM). 
 
Growth Medium: 
• 80% DMEM 
• 10% fetal calf serum (FCS) 
• 10% horse serum (HS) 
• 2mM L-glutamine  
• 100U/ml penicillin/streptomycin 
 
GLTs are plated every two days (70% confluent) on 35 mm culture dishes or on glass cover 
slips and cultured on GM for 2 days. When they reach approximately 80% confluence, GM 
is changed to fusion medium (FM) to induce cell fusion and differentiation. 
 
Fusion Medium: 
• 98% DMEM  
• 2% HS 
• 2mM L-glutamine 
• 100U/ml penicillin/streptomycin 
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On day 4, cells are transfected with α1S subunit cDNA. The liposome-mediated transfection 
(FuGENE, Roche) was found to be the best method for transfection of GLTs. After 
transfection, cells are cultured until day 7 on FM when they are very well differentiated with 
the α1S subunit completely expressed. On days 7 and 8 these cells are used for experiments. 
 
FuGENE transfection (according to the manufacturer`s instructions) 
• For each dish, mix 94 µl of DMEM with 6 µl of FuGene (pre-warmed at RT)  
• Incubate for 5 min 
• Provide 2 µg of DNA per dish in a transfection tube 
• Add 100 µl DMEM/FuGene mix and incubate for 15 min 
• Apply directly on the cells 100 µl of the transfection mix 
• Incubate for 2 min and then add 1.5 ml of FM  
 
? MDG cells are dysgenic myotubes generated from primary myoblasts (from newborn 
dysgenic mice)35, 36. These cells are very similar to the primary cultures with earlier fusion 
and, like GLTs, they are continuously cultured on plating medium (PM), enriched with 
bFGF. 
 
Plating  Medium 
• 80% F-10 Ham´s Media with L-Glutamine (200mM) and HEPES (25mM) 
• 20%FCS  
• 100U/ml penicillin/streptomycin 
• βFGF (2.5-5ng /ml) 
 
MDG cells grow on collagen coated (5µg/cm2) 10cm dishes (see protocol below) at 37ºC and 
5% CO2 until they reach 70-75% confluence. They are daily split 1:2 and plated on 35mm 
culture dishes or on glass cover slips coated with gelatin and cultured on GM for 1 day. On day 
2, GM is changed with FM (same used for GLT cells ) and on day 3 they are transfected with 
FuGENE, following the same protocol described for GLTs. The medium has to be changed  
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every day. They are cultured until day 9 for complete differentiation and used for the 
experiments. 
 
Collagen coating of culture dishes  
• Stock 1. Mix collagen (solid) type I with 0.1M Acetic Acid, for a final concentration of  
1mg/ml 
• Stock 2. Mix stock 1 solution with absolute ethanol and water in ratio of 1:1:2 
(concentration of collagen = 0.25mg/ml) 
• Coat each 10 cm culture dish (55cm2) with 1.1ml of stock-2 (5µg/cm2 collagen) 
• Leave the dishes dry for 30 min 
• Open the dishes  and leave them air dry for other 40 min       
• Wash two times the coated dishes  with PBS 1X 
• Let them perfectly dry. 
 
Construction of mutant α1S T1354S 
The wild-type (WT) clone GFP-α1S was generated by fusing α1S-subunit cDNA in-frame to the 
COOH terminus of the coding region of a modified green fluorescent protein (GFP) contained 
in a proprietary mammalian expression vector 37. To construct the T1354S point mutation in 
GFP-α1S [nucleotide numbers (nt) are given in parentheses and asterisks indicate restriction 
enzyme (RE) sites introduced by PCR with proofreading Pfu Turbo DNA polymerase], the 
silent AccI* (nt 4056) and SpeI* (nt 4526) RE sites together with a base substitution (nt 4066) 
that created a triplet coding for serine instead of threonine were introduced via the antisense 
primers by PCR. The AatII-SpeI* fragment (nt 3596-4526) produced by this PCR step was 
coligated with the XhoI/AatII fragment of plasmid GFP-α1S (nt 4328-5265) into the 
corresponding XhoI-SpeI RE sites of pBluescript. Subsequently, the XhoI/BglII fragment of 
this construct was inserted into the corresponding RE sites of GFP-α1S. For simplicity, we refer  
to this construct as α1ST1354S. All sequences generated and modified by PCR were checked 
for integrity by sequence analysis (MWG Biotech, Ebersberg, Germany). 
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Other α1S constructs 
 
Beside the α1SWT 35 and the mutant α1ST1354S, other α1S constructs were used as 
controls: a high conductive channel (α1S hc) and no-conductive channel (α1S nc). 
α1S hc is a new splice variant of α1S, characterized by very high and fast L-type calcium 
currents. These data are not yet published. 
α1S nc is a mutant α1S with a single point mutation D396K. This construct was generated 
by the substitution in the rabbit α1S of an Aspartic acid with Lysine, which is normally 
present in the medaka α1S. 
 
 
 
Immunocytochemistry 
Immunocytochemistry allowed us to verify the expression of the transfected α1S subunits, the 
correct colocalization of the two Ca2+ channels, DHPR and RyR1, in correspondence of the T-
tubule/SR junctions and the correct targeting of α2δ in the plasma membrane. For double 
labeling (Fig. 5), we used a combination of primary antibodies (anti-α1S or anti-GFP, anti-
RyR1 and anti-α2δ ) and fluorescent secondary antibodies (Tab.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Double immunostaining. Primary antibodies, raised in rabbit or mouse, and fluorescent secondary  (anti-
rabbit, anti-mouse) antibodies are directly applied to fixed myotubes. Secondary antibodies are chosen such to 
give a wide separation of the fluorescence signals. 
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According to the protocol described below, differentiated myotubes were fixed, the plasma 
membranes were permeabilized and the primary antibodies raised in rabbit or in mouse, were 
directly applied. In the next step, secondary antibodies, labeled with Alexa-488 or Alexa-598 to 
achieve a wide separation of the fluorescence signals, were applied. Alexa-488 was usually 
used with the anti-GFP antibodies so that the antibody label and the intrinsic GFP signal were 
both recorded in the green channel. 
Images were recorded on a Zeiss Axiophot microscope with a cooled charge-coupled device 
(CCD) camera and MetaView image-processing software (Universal Imaging, West Chester, 
PA). The screening of coverslips of transfected myotubes with labeling pattern was performed 
systematically with a 63x objective. 
 
 
Double immunofluorescence staining protocol 
• Rinse cells with  phosphate-buffered saline (PBS) at room temperature ( RT) 
• Fix cells in 100% methanol  at -20ºC for 10min 
• Rehydrate by plunging the coverslips with the adherent cells into PBS 
• Incubate the cells for 30 min with 5% normal goat serum in PBS containing 0.2% BSA 
and 0.2% Triton X-100 
• Incubate with primary antibodies prepared in PBS/BSA/Triton (Tab. 1 for the dilutions 
used) for 2 hours at RT or overnight at 4ºC 
• Wash in five changes of PBS/BSA/Triton 
• Incubate with fluorescent secondary antibodies (Tab.1) in dark for 1hour 
• Wash again in five changes of PBS/BSA/Triton 
• Mount in PPD-Glycerol (90% Glycerol, 0.1M Tris/HCl, pH=8, 5mg/ml p-phenylen 
diamin) to impede photobleaching. 
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Tab.1 
Primary Ab  Specificity dilution Secondary Ab (1:4000) 
Monoclonal, m1A   α1S 1:2000 Goat-anti mouse A-488 
Affinity purified, rbGFP  GFP 1:5000 Goat-anti rabbit  A-488 
Monoclonal, m20A  α2δ 1:1000 Goat-anti mouse A-594 
Affinity purified, rbRyR-162  RyR1 1:2000 Goat-anti rabbit A-488  
 Goat-anti rabbit A-594 
 
 
Whole-cell patch clamp  
Patch clamp is a technique that allows the study of ion channels in excitable cells. There are 
different variants of this technique, according to the aim of the researcher. In our case, to study 
the electrical behavior of all ion channels in the entire cell-membrane, we used the whole-cell 
recording method (Fig. 6). A glass pipette with a very small tip is used to make a tight contact 
with a tiny area (or patch) of cell membrane thereby showing electrical resistance in the giga 
Ohm range (so-called "gigaseal") Applying a strong suction, the membrane patch within the 
pipette mouth is disrupted and the solution inside the pipette (resembling the intracellular 
environment) becomes continuous with the cytoplasm of the cell. In this configuration, the 
membrane potential of a cell is clamped at a constant value (voltage clamp technique, Fig. 7) 
and the current that flows through the membrane at any particular potential can then be 
measured. The principle of this technique is to inject a current which is equal in amplitude but 
opposite in sign to the current flowing across the cell. This results in no net current flow across 
the membrane, and the membrane potential remains constant. Therefore, by measuring the 
current, which has to be injected to clamp the potential, the current flowing across the 
membrane can be determined. By measuring currents at different clamped membrane potentials 
it is then possible to characterize voltage-gated ion channels. 
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Fig. 6. Patch-clamp. A freshly pulled glass pipette with a tip diameter of few micrometers is pressed gently on 
the cell membrane to form a “gigaseal” (pipette resistance in giga Ohm range). When suction is applied to this 
patch pipette the membrane breaks under the pipette (open conformation) and the pipette solution diffuses into the 
cytoplasm. In this conformation and with a specific ion composition of the pipette solution and specific pulse 
protocols, it is possible to measure ion currents across the whole membrane of one cell.  
 
The Ca2+ currents were monitored in GLT myotubes on days 7 or 8, cultured in 35 mm culture 
dishes and mounted on an Olympus IX70 inverted microscope equipped with Hoffmann 
modulation contrast. All recordings were performed with an Axopatch 200A amplifier 
controlled by pClamp 7.0 software. Myotubes were bathed in an external solution that 
contained 145mM tetraethylammonium (TEA)-Cl, 10mM CaCl2 and 10mM HEPES (pH 7.4 
with TEA-OH). Patch pipettes were pulled from borosilicate glass (Harvard Apparatus), fire-
polished (Microforge MF-830, Narishige), and had resistances of 1.5–2.5 MΩ when filled with 
a solution consisting of 145mM Cs-aspartate, 2mM MgCl2, 10mM HEPES, 0.1mM Cs-EGTA, 
2mM Mg-ATP (pH 7.4 with CsOH). For simultaneous recordings of L-type currents and 
intracellular Ca2+ transients, the pipette solution additionally contained 0.2mM fluo-4 
pentapotassium salt. Depolarization-induced intracellular Ca2+ transients were monitored from 
a small rectangular region of the myotube with a photomultiplier detection system (Photon 
Technology International, South Brunswick, NJ).  
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Fig. 7. Voltage clamp patch clamp. Voltage clamp is based on a feedback system where a measured membrane 
potential is constantly compared and subtracted from a command voltage (CV), selected by the experimenter. Any 
difference is instantaneously compensated by current that is an accurate estimation of the ionic currents of the 
entire cell membrane. 
 
 
In some experiments, voltage-gated Ca2+ release was also monitored in the presence of a low 
concentration (2mM) of extracellular caffeine. According to a standardized protocol, L-type 
currents were elicited with 200-ms depolarizing steps from a holding potential of –80 mV to 
test potentials between –50 and +80 mV in 10-mV increments.  
In all recordings, linear leak and capacitative currents were digitally subtracted with a P/4 
prepulse protocol. To inactivate low voltage-activated T-type currents, each test pulse was 
preceded by a 1-s prepulse to –30 mV. Recordings were low-pass Bessel filtered at 2 kHz and 
sampled at 5 kHz. Ca2+ currents were normalized by linear cell capacitance (expressed in 
pA/pF). The L-channel conductance (G) for each test voltage (V) was obtained with the 
following equation: 
                                             G ( V ) = - ICa / ( V – Vrev ) 
where ICa is the peak Ca2+ current during the test pulse, Vrev is the extrapolated reversal 
potential, and V is the membrane potential.                                                                                                       
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The voltage dependence of L-type currents (Q) and intracellular Ca2+ release (∆F/F) was fitted 
according to a Boltzmann distribution: 
Y = Ymax /{ 1 + exp [ - ( V-V1/2 )/ K] } 
 
where Y is Q or ∆F/F; Ymax is Qmax or ( ∆F/F )max; V1/2 is the potential at which Y = Ymax/2; and k 
is a slope factor.  
The activation phase of Ca2+ current (0 to current level to 98% of peak current amplitude) was 
fitted with the following single and double-exponential functions: 
I (t) = Amono* [ exp ( -t/τmono)] + C 
I (t) = Afast * [ exp (-t/τfast)] + Aslow * [ exp (-t/τslow)] +C 
 
where I(t) is the current at time t after depolarization, Amono, Afast, Aslow are the steady state 
current amplitudes of each component with their respective time constants of activation (τmono, 
τfast, τslow ), and C represents the steady state peak current. 
All recordings were made at room temperature (~27°C) and data are reported as means ± SE. 
Only currents with a maximal voltage error <5 mV due to series resistance were analyzed with 
Clampfit 8.0 (Axon Instruments, Foster City, CA) and SigmaPlot 8.0 (SPSS) software. 
 
 
Measurements of caffeine induced Ca2+ release in myotubes 
Increased sensitivity to activation by caffeine (0.5, 1, 1.5, 2, 3, 4mmol/l) is a primary 
diagnostic tool for MH susceptibility. Here we tested whether the MH mutation T1354S also 
increased the caffeine sensitivity of Ca2+ release via RyR1. In these experiments, we applied 
different caffeine concentrations (0.5 to 40mM) on MDG myotubes, cultured on big glass 
cover slips. Because caffeine quenches the fluorescence of single-wavelength Ca2+ dyes (e.g., 
fluo-4), the detection of Ca2+ release at threshold concentrations might be obscured. For this 
reason, we performed the caffeine curves with Indo-1, a ratiometric Ca2+ indicator that exhibits 
a Ca2+-dependent shift in its emission wavelengths. Indo-1 requires a single excitation 
wavelength at 350nm and changes the emission spectra on binding Ca2+ from ~485 in Ca2+-free  
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medium to ~405 nm when the dye is saturated with Ca2+. Caffeine applications produce a 
comparable quench of both emission wavelengths and thus there is no effect on the resulting 
Indo-1 ratio (405/485) 38. First of all, the sensitivity of the photomultipliers to acquire Indo-1 
fluorescence was tested. A photomultiplier consists in a photocathode, several dynodes (in our 
case 9) and anode. When a photon of sufficient energy strikes the photocathode, it emits 
electrons due to the photoelectric effect. These few electrons are accelerated towards a series of 
additional electrodes called dynodes. Each dynode is placed at more positive potential then the 
previous one, so additional electrodes ca be generated at each dynode. This amplified signal is 
finally collected at the anode where it can be measured. The amplification of electrons depends 
on the number of dynodes and on the accelerating voltage. The voltage has to be selected in the 
way that the amplified signal could reach always the saturation. To this aim, the fluorescence 
of cells before and after Indo-1 loading was measured applying different test voltages to the 
photomultipliers. The amplified signal reached saturation when voltages higher than 800V 
were applied to both the photomultipliers (Fig. 14A). No difference was observed between 
untransfected and GFP-transfected cells (Fig. 14B).  
Fig. 14. Test of the photomultiplier sensitivity. To acquire maximal fluorescence signals, both photomultipliers 
(for both the emission wavelengths) require voltage higher than 800V(A). This test was made in untransfected and 
GFP transfected cells (B).  
 
 
Next question was to estimate the contribution of the cell autofluorescence and the background 
fluorescence, on the total signal. To this aim, the fluorescence of a small area with and without  
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cell was measured. Before loading the cells with Indo-1, the cell-autofluorescence represented 
the 25% and 20% of the background fluorescence signal, respectively at 405 and 485nm 
(Fig.15). After Indo-1 loading, the background fluorescence component was approximately 
25% and 15% of the total fluorescence signals at 405 and 485nm, respectively, whereas the 
cell-autofluorescence was approximately not higher than 5% of the total fluorescence signal 
(Fig. 15B). On the basis of these results, at the beginning of each recording, the background 
fluorescence, was measured in a cell-free area (corresponding exactly to the area with the 
selected cell ) and  automatically subtracted from the fluorescence signal, acquired during 
caffeine dose response recording. 
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Fig. 15. Components of fluorescence. The cell-autofluorescence contributes approximately for 20% to the 
background fluorescence before loading the cells with Indo-1 (A). After loading, the background fluorescence is 
approximately 20% of the total fluorescence signal whereas the cell-autofluorescence is approximately 5% (B). 
 
 
Myotubes were incubated for 1h at RT with 6μM Indo-1 plus 0.12% Pluronic in 1ml DMEM 
colorless. When loaded, myotubes were bathed in a normal rodent Ringer solution [containing 
145mM NaCl, 5mM KCl, 2mM CaCl2, 1mM MgCl2, and 10mM HEPES, pH 7.4] and excited 
at 350 nm with a DeltaRam illumination system (Photon Technology, Princeton, NJ). 
Fluorescence emissions at 405 (F405) and 485 (F485) nm were collected with a photomultiplier 
detection system, and results presented as ratio (R) of F405 to F485. Before each recording a 
small area of a single myotube was selected in the photomultiplier detection window. From a  
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window of the same size like the selected myotube region, background fluorescence was taken 
from a cell-free region of the glass cover slip and was automatically subtracted. At the 
beginning of each experiment, each responding cell, identified by its fluorescent signal 
(blinking), was electrically stimulated three times (10V for 2ms at 0.3 Hz) with two stimulating 
electrodes. The myotubes were then sequentially exposed to 60-s applications of different 
concentrations of caffeine (0.5, 0.7, 1.0, 3.0, 5.0, 10, 30 and 40mM), prepared in Ringer 
solution. Caffeine was directly applied to individual myotubes with a rapid perfusion system 
(Warner Instrument, Hamden, CT) that permits fast, local application of the agonist as well as 
rapid washout with control solution. Each caffeine application step was followed by a 60-s 
wash with Ringer solution.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Caffeine-induced Ca2+ release. Myotubes were loaded with Indo-1, a ratiometric Ca2+-indicator, 
comprising a shift in emission wavelength upon binding Ca2+. Each myotubes was perfused with different caffeine 
concentrations. The fluorescence emissions at 405nm and 485nm were collected in a photomultiplier detection 
system and displayed as ratios of F405 / F485. 
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Peak intracellular Ca2+ changes in response to agonist application are expressed as R (Ragonist 
– Rbaseline). Data were analyzed with FeliX (Photon Technology, Princeton, NJ) and SigmaPlot 
8.0 (SPSS, Chicago, IL) software packages. Caffeine concentration-response curves were fitted 
according to an equation of the following general form: 
 
f (x) = DmaxnH / 1+ ( EC50 / [D])nH 
 
where Dmax is the maximal response, [D] is the caffeine concentration, nH is the Hill coefficient, 
and EC50 is the concentration of caffeine at which the response is half-maximal. 
 
Field stimulation  
The Ca2+ release from intracellular store elicited by the action potential is a clear evidence for a 
normal EC-coupling mechanism. To verify this, myotubes previously loaded with fluorescent 
Ca2+ indicator Indo-1 are electrically stimulated in field stimulation experiments. The resulting 
change of Ca2+ levels is estimated via the changes in cellular fluorescence signals (visualised as 
“cell blinking”). 
Myotubes cultured on glass cover slips were incubated for 1h at RT with 6μM Indo-1. After 
incubation, the cover slip with cells was carefully washed and mounted on a specific chamber 
filled with Ringer solution on a Zeiss Axiovert epifluorescence microscopy. Transient 
elevations of intracellular Ca2+ were elicited by brief depolarizing pulses of 10V *2ms (at 
0.3Hz, 5Hz *2s and 20Hz *2s) through a pair of electrodes, placed in two opposite side of the 
incubation chamber. Action potential Ca2+ transients were measured during a sequential 
exposition of the myotubes to 0, 1 and 2mM caffeine solution prepared in Ringer with 0, 2 or 
10mM Ca2+. The fluorescence signals were detected by a photomultiplier system (PTI 814) and 
analyzed by with FeliX and SigmaPlot 8.0. 
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RESULTS 
 
The T1354S mutation does not affect α1S targeting 
Skeletal-type EC coupling depends on a protein-protein interaction between the sarcoplasmic 
Ca2+ release channel, RyR1, and the plasmalemmal voltage-gated Ca2+ channel, DHPR. This 
physical coupling requires a specific arrangement of four DHPRs in so called tetrads, 
positioned above every other RyR1 arranged in orthogonal arrays in the junctions of the 
plasma membrane or the plasmalemmal T-tubules with the SR 39.  
First we wanted to know, if mutation T1354S might hamper proper DHPR membrane 
targeting. Myotubes of the dysgenic (α1S-null) cell line GLT, transfected with GFP-α1SWT and 
GFP-α1ST1354S, were double labeled with an antibody against GFP, which is NH2-terminally 
fused to each DHPR-α1S subunits, as well as with an antibody against RyR1. 
Immunofluorescence analysis (Fig.8) showed that both, the transfected GFP-α1SWT and the 
GFP-α1ST1354S subunit are efficiently expressed in the dysgenic myotubes. The double 
labeling demonstrated that GFP-α1ST1354S, exactly as GFP-α1SWT, is organized in clusters 
that are perfectly colocalized with RyR1 clusters. This is particularly evident in the merged 
images (Fig.8C), in which the yellow foci represent the colocalization of GFP-α1S subunit 
(green) and RyR1 (red).  
The colocalization of the two channels is indicative of their location in junctions of the SR with 
the plasma membrane (peripheral couplings) or with the T-tubules (triadic couplings). DHPR-
RyR1 coclustering was comparable in myotubes transfected with GFP-α1S WT and GFP-
α1ST1354S. Thus, we concluded that the junctional targeting of DHPR is not affected by the 
MH point mutation T1354S, in the IVS5-S6 extracellular P-loop of α1S. 
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Fig. 8. DHPR-α1S junctional targeting in skeletal muscle. Double immunofluorescence labeling was performed 
with antibodies anti-GFP and anti-RyR1, in dysgenic myotubes transfected with GFP-α1SWT and GFP-
α1ST1354S. Both GFP-α1S subunits are expressed and arranged in clusters (A: green) that colocalize perfectly with 
clusters of RyR1 (B: red), as shown in the merged image (C: yellow). This colocalization indicates correct 
targeting of DHPR and RyR1 in the junctions of SR and plasma membrane. 
 
 
 
Current properties of α1S T1354S 
Skeletal-type EC coupling is known as a bidirectional signaling between DHPR and RyR1. In 
addition to the orthograde signaling, by which depolarization-induced conformational changes 
in the DHPR directly gate the opening of RyR1, also a retrograde signal exists, by which RyR1 
controls the Ca2+ channel activity of DHPRs. Whole-cell patch clamp allows us to study the 
bidirectional DHPR-RyR1 signaling and to characterize the biophysical properties of the two 
Ca2+ channels. Whole cell patch clamp and intracellular Ca2+ measurements were performed to 
test whether the mutation T1354S could affect the function of DHPR as Ca2+ channel and as 
voltage sensor in EC coupling. Ca2+ currents in response to 200-ms depolarizing steps from a 
holding potential of –80 mV to test potentials between –50 and +80 mV in 10-mV increments 
were recorded in transfected myotubes, identified by the GFP fluorescence. Ca2+ currents and  
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depolarization-induced intracellular Ca2+ transients were measured simultaneously using the 
fluorescent Ca2+ indicator Fluo-4.  
Representative recordings from dysgenic myotubes, transfected with GFP-α1SWT and GFP-α1S 
T1354S showed, that the expression of α1SWT and α1ST1354S restored L-type Ca2+ currents 
and Ca2+ transients (Fig. 9A-B). Comparable levels of Ca2+ influx in α1SWT and α1ST1354S 
expressing myotubes (Fig. 9B) indicated that the mutant channel was able to act as voltage 
sensor and Ca2+ conducting channel. At the same time, restored Ca2+ transients (Fig. 9A) 
indicated a functional interaction between DHPR and RyR1 channels. All the properties of 
Ca2+ currents are displayed in the Tab.2. 
 
Fig.  9. Patch clamp recordings and intracellular Ca2+ measurements. Ca2+ release from the SR (A) and L-
type Ca2+ currents (B) in response to 200ms depolarizing steps were recorded in α1SWT and α1ST1354S expressing 
myotubes. Voltage dependence and amplitudes of Ca2+ transients (C) and of Ca2+ currents (D). 
 
 
The averaged amplitudes and voltage dependence of intracellular Ca2+ transients and Ca2+ 
currents were comparable in α1SWT and α1ST1354S expressing myotubes (Fig. 9C and D, 
Tab.2). Nevertheless, at first sight, a difference in the activation phase of L-type Ca2+ currents 
in the two channels appeared evident. In Fig. 9B, a representative recording from an α1SWT 
transfected myotube shows slowly activating Ca2+ currents in contrast with the more 
accelerated traces recorded from α1ST1354S transfected myotube.  
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Tab.2. Properties of Ca2+ transients and Ca2+ currents in α1SWT and α1ST1354S expressing myotubes, 
determined from intracellular Ca2+ fluorescence measurements and whole-cell patch clamp recordings. None of 
these values compared were significantly different. 
 
            α1SWT     α1ST1354S  
Ca2+ transients      (ΔF/F)max 
             n 
     1.81 ± 0.14 
            40 
    1.74 ± 0.19 
            27 
Ca2+ currents      Imax (pA/pF) 
    Gmax (nS/nF) 
    Vrev (mV)    
             n  
     2.97 ± 0.20 
    103.6 ± 7.2 
       80 ± 1.25 
            30 
    3.26 ± 0.44 
    105.2 ± 11.2 
       83 ± 1.76 
            26 
 
As expected, the time to peak value (ttp), measured in correspondence of the maximal current 
traces (40mV or 50mV) was significantly (P<0.005) reduced from 99.87± 6.6 ms in WT (n=30) 
to 67.1±7 ms in the mutant channel (n=26) (Fig.10 A). Thus, the point mutation T1354S seems 
to play a role in the activation kinetic of skeletal muscle L-type Ca2+ currents. Similarly, the 
inactivation kinetic seems to be modulated by the T1354S mutation. The fractional inactivation 
(R200) of the maximal current traces at the end of the 200-ms depolarization pulse was slightly, 
but not significantly (P=0.065), increased from 2.08±0.53 % in α1SWT (n=30) to 4.12±1 % in 
α1ST1354S (n=26) transfected myotubes (Fig.10 B). 
 
Fig. 10.  Activation and inactivation analyses. Time to peak (ttp) of maximal Ca2+ currents is significantly 
(P<0.005) reduced in α1ST1354S (A). The inactivation of Ca2+ currents at the end of a 200ms depolarization step, 
(R200) is slightly (P=0.065) increased in α1ST1354S-expressing myotubes (B). 
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Fast activation kinetics is an intrinsic property of α1ST1354S 
The DHPR Ca2+ channel is a multimeric complex where the main subunit, α1S is responsible 
for voltage sensing and ion conduction, whereas the other subunits are involved in membrane 
targeting and modulation of current properties. In particular, α2δ−1 is the determinant of the 
characteristic slow kinetics of skeletal muscle L-type Ca2+ currents. In normal skeletal muscle, 
the activation phase is described by two components of an exponential function characterized 
by their specific time constants (τslow and τfast). These components represent two populations of 
Ca2+ channel complexes: channels with α2δ−1 and without α2δ−1. In 2005, Obermair et al.40 
described that the depletion of α2δ−1 results in accelerated activation kinetics and that the 
corresponding L-type Ca2+ currents are adequately fitted by a mono-exponential function with 
a single time constant (τmono), similar to the τfast in normal conditions. As the T1354S−α1S 
mutation accelerates the activation kinetics of the Ca2+ channel and also under consideration of 
its localization on the extracellular IVS5-S6 loop, it could be possible that this mutation could 
disturb the interaction between α1S and α2δ−1. In order to clarify the mechanism of fast 
activated Ca2+ currents observed for the α1ST1354S mutant channel, the maximal traces of L-
type Ca2+ currents, recorded in α1SWT and α1ST1354S, were fitted with mono and bi-
exponential functions. These analyses showed that in both channels (α1SWT and α1ST1354S)  
the fast and the slow components contribute equally to the total current amplitude (Fig.11A), 
even though the respective time constants (τslow and τfast) are significantly reduced (P < 0.05) in 
α1ST1354S (Fig.11B). Similarly, a fraction of recordings, fitted adequately by a mono-
exponential function, revealed for both constructs a single population of  channels with a time 
constant (τmono) similar to the respective τslow (slow activating channels). 
Taken together, these results reveal that the mutation T1354S does not disturb the balance 
between the fast and slow activating current populations and thus implicates an undisturbed 
interaction between the α1S and α2δ−1 subunits. However, the reduced time constant values 
(τslow and τfast),observed in α1ST1354S, indicate that the mutation affects directly the activation 
kinetic properties of the α1S subunit. 
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Fig. 11. Activation kinetics analysis. Kinetic analysis of Ca2+ currents shows the presence of both fast and slow 
components at similar ratios in α1SWT and α1ST1354S (A). However, the time constants of each component are 
reduced (* p < 0.05) for α1ST1354S (B). Numbers of recordings are indicated inside the columns. 
 
 
Tab 3. Parameters of Ca2+ current kinetics in α1SWT and α1ST1354S expressing myotubes. The  
Ca2+ currents were fitted with mono and bi-exponential equations. (* p < 0.05; ** p < 0.005) 
 
Ca2+currents  α1S WT (n) α1S T1354S (n) 
 ttp ** 
R200 
τ slow*  
τ fast*  
τ mono 
   99.8 ± 6.6     (30) 
   2.08 ± 0.5     (30) 
   30.4 ± 3.38   (18) 
   5.05 ± 0.36   (18) 
   35 ± 3.6        (12) 
  67.1 ± 7.3     (26) 
  4.12 ± 1        (26) 
  19.8 ± 3.7     (13) 
  3.69 ± 0.5     (13) 
  24.3 ± 5.0     (13) 
 
 
 
The evidence for intact α1S and α2δ−1 subunit interaction as provided by this detailed kinetic 
analysis has also been supported by double-immunofluorescence labeling of GFP-α1S and 
α2δ−1 in dysgenic myotubes transfected with GFP-α1SWT and GFP-α1ST1354S. As previously 
published, α2δ−1 subunits are diffusely expressed throughout the plasma membrane in 
dysgenic myotubes and it requires the expression of the α1S subunit for its proper targeting into 
the triads41. Fig.12 shows that the T1354S-α1S mutation does not alter the distribution of 
α2δ−1 in clusters (Fig.12b) that are perfectly colocalized with clusters of α1S (Fig.12a1, c1) 
indistinguishable from the situation in GFP-α1SWT expressing myotubes (Fig. 12a, b, c). 
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Fig. 12. α1S - α2δ−1 colocalization. Double immunofluorescence labeling was performed with antibody anti-GFP 
(a and a1) and anti-α2δ−1  (b and b1), in dysgenic myotubes transfected with WT and mutant α1S subunits. The 
α2δ−1 subunits are arranged in clusters (b and b1) that colocalize perfectly with α1S clusters (merged images c and 
c1). 
 
Malignant Hyperthermia phenotype and enhanced caffeine sensitivity 
The clinical manifestations of a malignant hyperthermia (MH) episode triggered by volatile 
anesthetics and depolarizing muscle relaxants are associated with a non-physiological increase 
of myoplasmic Ca2+ concentration. In addition, it is well known that skeletal muscle from MH 
susceptible (MHS) individuals show a higher response than muscles from MH normal (MHN) 
to RyR1 activators like caffeine and 4-chloro-m-cresol (4-CmC). This enhanced sensitivity is 
still used for the diagnosis of MH susceptibility by IVCT.  
To test if the caffeine-induced Ca2+ release possibly contributes to a higher level of 
intracellular Ca2+ in presence of the T1354S α1S mutation, Ca2+ currents and Ca2+ transients  
were patch-clamp recorded in α1SWT and α1ST1354S expressing myotubes after application of 
external solution containing 2mM caffeine. The averaged amplitudes and the voltage 
dependence of intracellular Ca2+ transients and of Ca2+ currents showed no differences between 
α1SWT and α1ST1354S expressing myotubes (Fig.13A). Nevertheless, the time to peak values  
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were found again significantly (P<0.02) reduced in α1ST1354S (Fig.13B), thereby confirming 
the accelerated activation previously observed also under 2mM caffeine administration. 
 
                                                                               
Fig. 13. Patch clamp recordings and intracellular Ca2+ 
measurements in external solution containing 2mM 
caffeine. 
Amplitudes and voltage dependence of Ca2+currents and 
Ca2+ transients, recorded in presence of 2mMcaffeine (A) 
 
Time to peak (ttp) of Ca2+ currents were significantly 
(* P<0.02) reduced in α1ST1354S (B) 
 
                                                                                                       
 
      
 
Enhanced caffeine sensitivity of RyR1 under control of α1ST1354S ? 
As already mentioned before, caffeine is an activator of RyR1 and is able to trigger Ca2+ 
mobilization from the SR. The activation of RyR1 induced by caffeine seems to be 
downregulated by the DHPRα1S subunit42 and is dependent on resting Ca2+ level43, normally 
increased in the MH phenotype. According to these findings, it can be hypothesized that the 
T1354Sα1S-mutation could account for an increased caffeine sensitivity of RyR1 by a  
hampered control function on the RyR1 activation. To this aim, caffeine dose response was 
assessed in α1S-null, α1SWT and α1ST1354S-expressing GLT myotubes. Because caffeine 
quenches the single wavelength emission of Fluo-4 fluorescence, myotubes were loaded with  
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the ratiometric Ca2+ dye Indo-1. At the beginning of each caffeine dose-response recording, a 
rapid voltage-gated Ca2+ release was elicited by applying a train of three extracellular electrical 
stimuli (60V for 2ms) to confirm the functional expression of the DHPRs in transfected 
myotubes (Fig.16, see arrowheads). As expected, not any electrically evoked Ca2+ transient 
was observed in dysgenic GLT myotubes (left panel). Subsequently, the selected myotube was 
exposed to 60-s applications of caffeine with a stepwise increase from 0.3 to 40 mM, followed 
by a 60-s washout with Ringer solution (Fig.16). 
 
 
 
Fig. 16. Representative traces of caffeine concentration-response curves. Dysgenic untransfected and α1SWT 
and α1ST1354S transfected myotubes (GLT cell line) were loaded with Indo-1. At the beginning of each recording, 
electrical stimuli were applied to verify the expression of DHPRs. Increasing concentrations of caffeine (0.3 – 40 
mM), separated by washing steps, were sequentially applied. 
  
 
 
The caffeine response curve, in which each point represents the averaged maximal response to 
each caffeine concentration, showed that there was not a complete Ca2+ release even applying 
40mM caffeine. As shown in Fig.17 (lines in black) dysgenic myotubes (cell line GLT), 
transfected or untransfected, seem to need higher caffeine concentrations to induce maximal 
release from SR. This finding is in contrast with previously published results42 (Fig.17, red 
lines), where maximal Ca2+ release from SR was reported to be induced with 20 and 30mM 
caffeine.    
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Fig. 17. Caffeine concentration-
response curves comparing GLTs 
and published values. 
The averaged values of maximal 
response, at the different caffeine 
concentrations are fitted according to 
the Hill equation. The caffeine dose 
response curves recorded in GLT 
myotubes (black lines) do not show 
saturation at highest (30-40mM) 
caffeine concentrations. In contrast, 
MDG cells (data taken from Weiss at al. 
200442) reacted with a maximal 
response to even lower caffeine 
concentrations (red lines). 
 
 
 
To test whether this weak response was related to an intrinsic characteristic of the GLT cell 
line or to a wrong adjustment of the perfusion system, an immortalized cell line isolated 
directly from the transgenic Immortmouse, expressing the thermolabile SV40 large T antigen 
tsA58, was used (courtesy BE Flucher and G Kern)44. This cell line resembles much better the 
phenotype of primary mouse myotubes, and thus it was possible to verify that the weak 
caffeine response is only related to specific GLT cell line characteristics (Fig.18) 
 
Fig. 18. Summary of caffeine 
concentration-response curves. 
The response to caffeine is similar for 
MDG cells and immortalized 
myotubes in contrast to GLT 
myotubes that show weak caffeine-
induced Ca2+ release and do not reach 
saturation even under high caffeine 
concentrations (40mM). 
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According to these findings, the dysgenic muscle cell line, defined as MDG cells 45 (courtesy 
of PD Allen and RT Dirksen) was used to proceed with the functional characterization of 
mutant α1ST1354S.   
 
 
Caffeine dose-response of α1ST1354S expressed in MDG myotubes 
Also for the MDG myotubes, liposome-mediated transfection (FuGENE and lipofectamine) 
was found to be the best method. As shown in Fig.19, patch clamp recordings and 
immunocytochemistry showed the correct expression of the transfected α1S-subunits by 
restoration of Ca2+ currents, intracellular Ca2+ transients and proper membrane targeting. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19. Correct expression and targeting of transfected α1S subunits in MDG myotubes. L-type Ca2+ currents 
(A) and intracellular Ca2+ transients (B) in response to 200-ms depolarization steps were restored after expression 
of GFP-α1SWT and GFP-α1ST1354S in MDG myotubes. Immunocytochemistry confirmed the perfect 
colocalization of α1S subunits and RyR1 (C). 
 
The caffeine dose-response experiments described above were repeated in MDG cells 
following the same protocol as used for GLTs. 
Myotubes were loaded with the ratiometric Ca2+ dye, Indo-1 for 1 hour at 37°C. At the 
beginning of each recording, the selected DHPRα1S-transfected myotube was electrically 
stimulated (10V*2ms) and the obtained voltage-gated Ca2+ release was judged as a  
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confirmation of the functional expression of the DHPR. Subsequently, the myotube was 
exposed for 60-s periods to increasing concentrations of caffeine (0.3-0.7-1-3-10-30-40mM), 
with each perfusion period separated by 60-s washes with Ringer solution. Caffeine 
concentration-response curves obtained from the averaged values of the maximal response to 
each caffeine concentration in untransfected MDG myotubes (n=19) as well as in α1SWT 
(n=18) and α1ST1354S (n=21) expressing myotubes were fitted according to the Hill equation. 
Even though maximal caffeine-induced Ca2+ release is similar in dysgenic, α1SWT and 
α1ST1354S-expressing myotubes, the caffeine-induced Ca2+ release curve is shifted to lower 
caffeine concentrations in untransfected dysgenic compared to α1SWT-expressing myotubes. 
However, α1ST1354S-expressing myotubes showed a sensitivity of caffeine-induced Ca2+ 
release intermediate between the dysgenic and WT values (Fig 20A). A similar graduation was 
also found if the data were analyzed by counting cells responding to lower (3 and 5 mM) 
caffeine concentrations. Responders were more frequently found in untransfected dysgenic 
myotubes, followed by α1ST1354S-expressing and subsequently α1SWT-expressing myotubes 
(Fig 20B).    
 
 
 
Fig. 20. Caffeine dose-response curves in the MDG expression system.  Each point represents the average of 
maximal caffeine-responses, relative to the baseline taken immediately before every caffeine application. The 
threshold for caffeine-induced Ca2+ release was slightly lower for α1ST1354S-expressing than for α1SWT-
expressing myotubes (A). The frequency of responding cells to the threshold caffeine concentrations, 3 and 5 mM 
was graduated: untransfected dysgenic > α1ST1354S-expressing > α1SWT-expressing myotubes (B). 
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Effects of additional Ca2+ influx through a fast activating Ca2+ channel? 
As mentioned above, L-type Ca2+ currents revealed an accelerated activation for α1ST1354S 
channels in response to 200ms depolarization steps in whole-cell patch clamp experiments. 
Now it was of interest, if a faster activating Ca2+ channel could have any physiological effects 
on the intracellular Ca2+ concentration and thus, consequently, might influence the Ca2+ 
sensitive RyR1. The integral of the area under the maximal L-type Ca2+ current trace (30-
40mV potentials) during the initial phase of depolarization gives an estimation of the Ca2+ 
influx in this specific time-period. The Ca2+ influx taken from the first 20ms of depolarization 
resulted in considerably higher values for α1ST1354S currents compared to WT (Fig.21A, B). 
To even enhance the putative effects of an accelerated Ca2+ influx, a new, high conductive (hc) 
control construct, α1Shc, was introduced in the experimental plans. The α1Shc-subunit is a 
splice variant of α1S that showed in patch clamp recordings accelerated activation and high Ca2+ 
conductivity, approximately 7-8 times higher than Ca2+ currents measured from α1S WT 
expressing myotubes. Ca2+ influx, in the first 5-20ms of the depolarization step (with rather the 
shorter time frames mirroring a skeletal muscle action potential) resulted in distinct values at 
all time frames with a continuous graduation of α1SWT < α1ST1354S < α1Shc (Fig.21C).  
Fig. 21. Ca2+ influx in slow and fast activating Ca2+ channels. The integral of the area under the maximal Ca2+ 
trace shows an increased Ca2+ influx in the first 20 ms of depolarization through α1ST1354S channels compared to 
WT channels (A, B). Ca2+ influx was even higher for the α1Shc control construct (C). 
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To test whether this additional Ca2+ influx observed in fast activating channels could affect the 
intracellular Ca2+ concentration and thus intracellular Ca2+ transients, Ca2+ release via RyR1 
was evoked by extracellular electrical field stimulation. Electrical pulse train application is 
easy to control and it is possible to modify the frequency, the number of pulses, the duration 
and the intensity of each pulse. In the field stimulation protocol designed for a first run, 
transfected MDG myotubes were stimulated with three 10V * 2ms pulses at 0.3Hz followed by 
a pulse train of 20Hz * 2s (Fig. 22A) to sum up the putative Ca2+ effects in this tetanic 
stimulation. This stimulation train was repeated during a sequential exposition to 0, 1 and 2mM 
caffeine solution prepared in Ringer with addition of 2 or 10mM Ca2+. Each application was 
followed by 60-s washes with Ringer solution without caffeine. Under this tetanic stimulation 
protocol, no differences in Ca2+ release between α1SWT and α1ST1354S-expressing solutions 
(Fig. 22C).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 22. High frequency field stimulation. MDG cells were stimulated with short pulses (10V * 2ms) and with a 
tetanic pulse at 20Hz * 2s (A). No differences in SR Ca2+ release under tetanic stimulation were observed 
(measured as the plateau of the tetanus ± SE) in 2mM and 10mM extracellular Ca2+, respectively (B, C). Numbers 
of recordings are indicated inside the columns. 
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Considering that high stimulation frequency might not have been the appropriate tool to 
distinguish the effects of elevated Ca2+ influx on the SR Ca2+ release, the frequency of the 
tetanic stimulation was reduced to 5Hz for a new series of measurements, performed in 
extracellular solutions containing 10mM Ca2+. 
Again, no differences were observed in Ca2+ release after application of tetanic stimulation, 
comparing α1SWT, α1ST1354S and α1Shc-expressing myotubes. However, a change in SR Ca2+ 
release induced by single pulses at 0.3Hz could be identified when comparing α1SWT and the 
faster activating channels, after perfusing the expressing cells with solutions containing 10mM 
Ca2+ and 1-2mM caffeine (Fig. 23A, B). The integral of the Ca2+ release transient peaks (a more 
accurate measure of Ca2+ release than the height of the peak) showed a significant 
amplification (P<0.005) under caffeine perfusion in α1Shc-expressing myotubes compared to 
α1SWT-expressing myotubes. However, α1ST1354S-expressing myotubes are positioned 
between these values, and thus show exactly the same tendency (Fig. 23C). 
 
 
 
 
Fig. 23. Low frequency field stimulation. When MDG cells were stimulated at 0.3Hz and at 5Hz, SR Ca2+ 
release induced by single pulses (0.3Hz) was elevated (** P<0.005) under 1 and 2mM caffeine in α1ST1354S and 
α1Shc compared to α1SWT-expressing myotubes. A plot of the height of the Ca2+ release peaks ± SE (B) and the 
integral of the transient peaks ± SE (C) are shown. Numbers of recordings are indicated inside the columns. 
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To test the hypothesis that extracellular Ca2+ influx is responsible for this additional activation 
of SR Ca2+ release under the influence of caffeine, which is especially prominently seen with 
the higher Ca2+-conducting α1S constructs, field stimulation experiments at low frequency 
(10V * 2ms at 0.3Hz) were performed during the sequential application of Ca2+-free and 
10mM Ca2+-containing external solutions, both in combination with 1 and 2mM of caffeine, 
respectively (Fig.24). 
 
 
Fig. 24. Field stimulation in 0 and 10mM extracellular Ca2+.  Integral of SR Ca2+ release ± SE was comparable 
for all the constructs (α1SWT, α1ST1354S and α1Shc) in 0mM extracellular Ca2+ but significantly increased (* 
P<0.05; ** P<0.005) in α1Shc in presence of 10mM extracellular Ca2+ and 1-2mM of caffeine. 
 
 
Alternatively, the elevated SR Ca2+ release observed in myotubes expressing the fast activating 
/ high conductive Ca2+ channels could be due to an elevated SR Ca2+ loading or to a more direct 
effect of the action potential induced Ca2+ influx on RyR1 sensitization and thus activation. To 
investigate the underlying mechanism, MDG cells were incubated for 2min with 10mM Ca2+ to 
allow sufficient SR loading. Subsequently, three electrical pulses (10V * 2ms) were repeatedly 
applied during a sequential 30sec-exposure to 2mM Ca2+ together with either 0, 1 or 2mM 
caffeine (Fig.25A).  
The tendency of an increased SR Ca2+ release in α1ST1354S and α1Shc-expressing myotubes 
compared to α1SWT was found again and resembled the situation without preloading. This 
effect was even more pronounced during caffeine perfusion (Fig.25B), suggesting that Ca2+ 
influx does primarily not affect SR loading properties but rather interact directly with RyR1 
and hence sensitizes SR Ca2+ release. 
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Fig. 25. Field stimulation in 2mM Ca2+ after preloading with 10mM Ca2+. Action potential induced Ca2+ 
release in 2mM Ca2+ after a 2min preloading period with 10mM Ca2+ (A) resulted in more robust Ca2+ transient 
peaks (* p<0.05) in α1ST1354S and α1Shc, than in α1SWT-expressing myotubes during caffeine perfusion. Integral 
of the transient peaks ± SE is shown in (B). Numbers of recordings are indicated inside the columns. 
 
 
The hypothesis that Ca2+ influx enhances the caffeine-induced SR Ca2+ release was tested 
again in a new set of field stimulation experiments, using additionally the non- Ca2+-conductive 
α1SD396K subunit (courtesy Grabner, Schredelseker, Shrivastav; unpublished construct). The 
pore loop point mutant α1SD396K, when expressed in GLT myotubes was unable to restore L-
type Ca2+ currents despite the existence of intracellular Ca2+ transients comparable in 
amplitude and voltage dependence to those in α1SWT-expressing myotubes. 
Action potential-induced SR Ca2+ release was again recorded in transfected MDG myotubes by 
applying three single pulses (at 10V * 2ms) during the application of extracellular solutions 
containing different concentrations of Ca2+ and caffeine.The resulting SR Ca2+ release was 
comparable in α1SD396K and α1SWT-expressing myotubes but significantly increased 
(*p<0.05) for the highly conductive channel α1Shc. Again, the α1ST1354S expressing myotubes 
showed an intermediate response between α1SWT and α1Shc during caffeine application, 
confirming the previously observed tendency (Fig. 26). These findings provide strong evidence 
that elevated Ca2+ influx through the DHPR-α1S plays a role in the sensitizing of the skeletal 
muscle RyR1 and thus leads to an activation of Ca2+ release.  
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Fig. 26. Field stimulation in α1SD396K expressing MDG myotubes. Action potential induced SR Ca2+ release 
was comparable in α1SD396K and α1SWT-expressing myotubes but higher (*p<0.05; *p<0.06) in α1Shc expressing 
myotubes during caffeine applications.  
 
 
Concluding, we can summarize that the MH-associated α1ST1354S L-type channel mutation is 
characterized by a faster activation that results in an increased Ca2+ influx during the action 
potential. This additional Ca2+ influx together with the higher caffeine sensitivity of Ca2+ 
release, observed in the presence of the point mutant α1ST1354S channel, accounts for 
increased depolarization-dependent intracellular Ca2+ transients that could explain the MH 
phenotype. 
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DISCUSSION 
 
MH is a pharmacogenetic disorder of skeletal muscle EC coupling, characterized by an 
abnormal regulation of Ca2+ release from the SR that leads to an increased and non-
physiological intracellular Ca2+ level. The pathogenic mechanisms of MH, even still not 
completely and well defined, seems to arise from abandoned Ca2+ release due to an increased 
sensitivity of the SR Ca2+ release channels RyR1 to different activating stimuli.  
The first studies, made in a porcine model for MH showed an altered Ca2+-induced Ca2+ release 
(CICR) mechanism of SR46 and an increased sensitivity of RyR1 to halothane, succinylcholine, 
caffeine and 4-chloro-m-cresol47,48. Beside these, also a reduced inhibitory effect of Mg2+ and 
Ca2+ has been described to account as well for the altered gating of MH susceptible (MHS) SR 
channels49, 50. In most of the cases, MH susceptibility is associated to mutations in the gene 
encoding RyR1, but several other genes are also associated to this disorder. However, so far the 
mutations α1SR1086H27 and α1ST1354S28 of the α1S subunit of the DHPR are the only specific 
MH mutations that have been identified in a protein other than RyR1.  
Apart from MH crisis episodes induced upon the exposition to volatile anesthetics or 
depolarizing muscle relaxants, MHS patients do not show clinically relevant symptoms in 
normal life. Thus, the single point mutations associated with MHS can not severely affect the 
muscle physiology but only show rather marginal effects under specific and stringent 
conditions. In this study we evaluated the functional expression and physiological impact of 
the recently detected mutant α1ST1354S28 on SR Ca2+ release using different experimental 
approaches with the combined use of pharmacological stimuli to describe a new pathogenic 
mechanism of MH. 
 
Normal membrane expression, triad targeting and voltage-sensing in 
α1ST1354S expressing myotubes. 
As previously described, the α1S subunit contains molecular domains for interactions with the  
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other accessory subunits 9 of the DHPR and with the RyR15. Thus, it was important to verify 
whether point mutation T1354S could affect the membrane expression of the α1S subunit and 
consequently the correct muscle-specific arrangement of DHPR and RyR1. 
As shown in Fig.8, the immunocytochemistry analysis proved the correct expression and 
distribution of α1ST1354S in clusters that perfectly colocalized with RyR1 clusters. This means 
that the point mutation T1354S does not affect the correct location of the two channels in 
junctions of the SR with the plasma membrane (peripheral couplings) or with the T-tubules 
(triadic couplings), which is a prerequisite for the physical DHPR-RyR1 interaction. Second, 
and most important for muscle physiology, was to test the effect of mutation T1354S on 
skeletal muscle EC coupling. Skeletal muscle DHPRs play a pivotal role in the process by 
which depolarization of the sarcolemma causes the release of Ca2+ from the SR, ultimately 
resulting in muscle contraction. Skeletal muscle DHPRs are low conductance L-type Ca2+ 
channels51 that are characterized by slow activation kinetics, requiring more than 100 ms to 
open fully52. Therefore, L-type Ca2+ currents in whole-cell patch clamp experiments are 
elicited by 200ms depolarization steps.  
In contrast to the previously described and characterized MH mutant α1SR1086H42, where the 
L-type current density was reduced and the voltage gated Ca2+ release activated at more 
negative voltages, in α1ST1354S-expressing myotubes the amplitudes and voltage dependence 
of L-type Ca2+ currents and Ca2+ transients in response to 200ms depolarization step were 
indistinguishable from those of α1SWT-expressing myotubes (Fig.9). As skeletal muscle 
DHPRs are understood to act mainly as voltage sensors for EC coupling by providing a 
mechanical link between sarcolemmal depolarization and the release of Ca2+ from the SR, we 
concluded that the mutation T1354S does not affect the voltage sensor function of the α1S.  
However,  the finding that the T1354S mutation in DHPR-α1S did not enhance the sensitivity 
of the Ca2+ release to activation by the endogenous stimulus (depolarization) did not exclude 
the possibility that it could affect the Ca2+ release upon activation with a pharmacological 
activator of RyR1 (i.e. caffeine). To test this hypothesis, we measured L-type Ca2+ currents and 
Ca2+ transients in response to 200ms depolarization step in the absence and presence of 2mM 
caffeine. No difference was found in voltage-dependence and amplitude between the α1SWT  
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and α1ST1354S-expressing myotubes even in presence of caffeine (Fig.13). Nevertheless,  
action potential-induced Ca2+ transients measured in presence of 1 and 2mM caffeine resulted 
to be higher in α1ST1354S compared to α1SWT-expressing myotubes (Fig.23). These results  
indicate that the mutation T1354S slightly enhanced the sensitivity of Ca2+ release to activation 
by caffeine and that it is not possible to discriminate this minute effect during a long and non-
physiological depolarization stimulus of 200ms.  
 
T1354S accelerates Ca2+ current kinetics 
Although amplitudes and voltage dependence of Ca2+ current and Ca2+ transients in 
α1ST1354S-expressing myotubes were similar to the α1SWT control, current kinetics were 
different. The reduction of the time-to-peak value in the mutant T1354S channel indicated an 
accelerated activation of Ca2+ currents.  
Previous studies9 showed that the Ca2+ current kinetics are determined by the α2δ−1 subunit 
and that the extracellular regions of α1S- subunits are involved in the interaction with the 
α2δ−1subunit53. According to these findings and according to our first results showing that the 
T1354Smutation, located in the IVS5-S6 extracellular P-loop of α1S, accelerates the Ca2+ 
current kinetic, we hypothesized that this T1354S mutation could disturb the interaction 
between α1S - α2δ−1subunits. In normal muscle cells there are two populations of Ca2+ channel 
complexes: slow and fast activating channels, respectively, that are understood as existing with 
and without α2δ−1 subunits. If mutation T1354S had affected the correct association of α2δ−1 
to α1S, the balance between the two current components would have been altered, with a 
predominance of the fast activating component. Our kinetic analysis showed that in the mutant 
α1ST1354S channel, exactly as in the α1SWT, the slow and fast components contributed 
equally to the total current amplitude (Fig.11). This provides evidence that the T1354S 
mutation does not disturb the functional interaction of α2δ−1 and α1S subunits. The same 
conclusion was drawn from immunocytochemistry, where we observed perfect colocalization 
of α2δ−1 and α1S clusters (Fig.12). This was consistent with previously published studies in  
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which was demonstrated that this is the fact only in normal myotubes, while in dysgenic 
myotubes the α2δ−1 subunit is diffusely expressed and mistargeted into the plasma 
membrane41.  
Even though mutation T1354S obviously does not disturb the balance between the two  
channel populations, the significantly reduced time constants (τslow and τfast) of both the two 
components in the mutant channel proved that the mutation T1354S affects the intrinsic kinetic 
properties of the Ca2+ channel.  
 
Caffeine sensitivity of RyR1 in α1ST1354S-expressing myotubes 
It was previously shown that skeletal muscle from MHS individuals and animals have a lower 
pharmacological threshold for and an exaggerated response to submaximal concentrations of 
caffeine54 and 4-chloro-m-cresol (4-CmC)55 compared to those from MH-nonsusceptible 
(MHN) subjects. This enhanced sensitivity is widely used as part of the clinical diagnosis of 
MHS in humans and has been confirmed experimentally in swine56. The molecular and cellular 
basis for enhanced sensitivity to pharmacological agents in MHS has remained unclear. Some 
evidences suggest that the amplified intracellular Ca2+ release at submaximal concentrations of 
caffeine and 4-CmC is closely associated with the high resting [Ca2+]i observed in these cells57. 
However, other studies revealed that at rest, before activation, the DHPR exerts a negative 
long-range allosterism on RyR1, reducing its sensitivity to direct agonists such as caffeine58. 
This hypothesis was also confirmed by Weiss et al. proposing that the MH mutation R1086H in 
the DHPR α1S subunit, located in the III-IV intracellular loop, disrupts this negative DHPR-
mediated allosteric regulation of the SR Ca2+ release mechanism42. Surprisingly, we also found 
that the threshold for caffeine-induced Ca2+ release is slightly lower in α1ST1354S-expressing 
myotubes compared with that of α1SWT-expressing myotubes and approximates the values 
obtained from dysgenic myotubes. However, in contrast to the R1086H-expressing myotubes, 
we did not find elevated resting Ca2+ level in α1ST1354S-expressing myotubes42. Considering 
that at threshold concentration (3mM and 5mM) of caffeine a major number of α1ST1354S- 
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expressing myotubes responded, we could conclude that the MH T1354S mutation also 
weakens the control mechanism of DHPR-α1S on SR Ca2+ release (Fig.20). 
 
The role of increased Ca2+ influx and of increased RyR1 caffeine sensitivity 
on SR Ca2+ release   
Finally the question arises, whether and how the acceleration of Ca2+ channel activation   
contributes to an increased SR Ca2+ release that might account for elevated intracellular Ca2+ 
levels characterizing the MH phenotype, and whether the observed slightly increased caffeine 
sensitivity of SR Ca2+ channels in α1ST1354S-expressing myotubes enhances this effect. Under 
physiological conditions, a brief action potential (few ms) triggers conformational changes of 
the DHPR by the gating charge movement of its voltage sensor, which, in turn, activates the 
RyR1 in the SR to open. L-type currents induced by a long depolarization steps like used in 
regular patch-clamp protocols (200ms), do not represent the physiological situation in the 
skeletal muscle cell and the effect of fast activation might be underestimated. In fact, if we 
consider the integral of the area in the first 5-20ms of the maximal L-type Ca2+ current traces 
we can estimate a higher Ca2+ influx through the faster activating channels compared to the 
control. This difference is no more evident when integrating the area of the maximal L-type 
Ca2+ current traces over the full 200ms period. On this finding, the next question was, whether 
this additional Ca2+ influx affects the SR Ca2+ release mechanism and whether it is enhanced in 
presence of low concentrations of caffeine. A this point, expecting that the effects of a MH 
point mutation on Ca2+ channel activity is rather tiny and marginal, and thus can not be easily 
discriminated and evaluated, we introduced in our experimental plans an additional α1S 
construct (α1Shc), characterized by robustly increased Ca2+ conductivity (circa 8-fold higher 
than the α1SWT subunit) and accelerated activation. Thus, subunit α1Shc was expected to 
enhance the hypothesized effects of the α1ST1354S subunit on the SR Ca2+ release mechanism 
and hence support the evidence that the acceleration of the Ca2+ channel activation contributes 
to a higher Ca2+ influx. And indeed, in field stimulation experiments at low frequency (0.3Hz) 
and 10mM extracellular Ca2+ solution, we could find higher action potential-induced Ca2+  
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release in α1ST1354S and α1Shc-expressing myotubes than in those expressing α1SWT. This 
effect was even more pronounced in the presence of low caffeine-concentrations. In 
accordance to our working hypothesis that Ca2+ influx plays a role, even marginal, on the SR 
Ca2+ release, we should expect in Ca2+-free extracellular solutions no differences in action 
potential-induced Ca2+ release between normal and faster activating Ca2+ channels. And this 
was exactly what we observed (Fig. 24). Surprisingly, in Ca2+- free solutions even the caffeine 
effect on Ca2+ release was no more evident. However, this can again be judged as a prove that 
extracellular Ca2+ has a profound effect on caffeine-induced Ca2+ release and on SR Ca2+ 
stores59. Finally, by Ca2+ pre-filling of the SR stores60 (Fig.25) we could demonstrate, that 
additional Ca2+ influx has rather a direct effect on RyR1 activation and does not affect the SR 
loaded state. In all our experiments we could continuously observe increased electrically-
induced Ca2+ release in α1ST1354S and α1Shc-expressing myotubes during the application of 
Ca2+ and caffeine, suggesting a concerted effect of Ca2+ influx and caffeine on the activation of 
RyR1. An additional concept to confirm the Ca2+ free recording results with the consequential 
changes in SR Ca2+ release in presence of 1 and 2mM caffeine, would have been to block the 
DHPR channels either with La3+ and Cd2+ or with the organic DHPR blocker nifedipine. 
Unfortunately, these DHPR blockers increase the sensitivity of RyR1 to caffeine61. Thus, the 
only additional way to examine again the combined effect of Ca2+ influx and caffeine on the 
activation of RyR1 was to use a non-conductive α1S subunit (α1SD396K). The comparable Ca2+ 
release in α1SD396K and α1SWT-expressing myotubes (Fig.26) proved again our hypothesis of 
a concerted mechanism of Ca2+ influx and caffeine on SR Ca2+ release. Taken together, the 
evidence provided here suggests that in myotubes expressing the MH α1ST1354S mutant the 
additional Ca2+ influx, due to the accelerated kinetics of the Ca2+ channels together with higher 
caffeine sensitivity of RyR1, accounts for an increased intracellular Ca2+ level that could 
explain the MH phenotype by a hitherto unnoticed mechanism. 
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